EYES
Income statement / Annual
Last year (2024), Second Sight Medical Products, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Second Sight Medical Products, Inc.'s net income was -$23.49 M.
See Second Sight Medical Products, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2024 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$0.00 |
-$130.00 K |
-$500.00 K |
$3.38 M |
$6.90 M |
$7.96 M |
$3.99 M |
$8.95 M |
$3.40 M |
$1.56 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$2.15 M
|
$4.89 M
|
$5.12 M
|
$10.08 M
|
$5.29 M
|
$3.56 M
|
$5.63 M
|
| Gross Profit |
$0.00
|
-$130.00 K
|
-$500.00 K
|
$1.23 M
|
$2.01 M
|
$2.85 M
|
-$6.09 M
|
$3.66 M
|
-$160.28 K
|
-$4.06 M
|
| Gross Profit Ratio |
0
|
1
|
1
|
0.36
|
0.29
|
0.36
|
-1.53
|
0.41
|
-0.05
|
-2.6
|
| Research and Development Expenses |
$15.75 M
|
$2.37 M
|
$4.84 M
|
$13.14 M
|
$10.01 M
|
$7.89 M
|
$5.35 M
|
$3.04 M
|
$5.04 M
|
$3.25 M
|
| General & Administrative Expenses |
$8.93 M
|
$6.32 M
|
$5.94 M
|
$9.23 M
|
$10.69 M
|
$10.93 M
|
$10.08 M
|
$8.22 M
|
$6.57 M
|
$4.17 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$701.00 K
|
$6.10 M
|
$11.34 M
|
$9.57 M
|
$8.99 M
|
$8.94 M
|
$6.84 M
|
$3.30 M
|
| Selling, General & Administrative Expenses |
$8.93 M
|
$6.32 M
|
$6.64 M
|
$15.33 M
|
$22.03 M
|
$20.50 M
|
$19.07 M
|
$17.16 M
|
$13.41 M
|
$7.47 M
|
| Other Expenses |
$0.00
|
$378.00 K
|
$1.69 M
|
$3.35 M
|
$4.60 M
|
$3.06 M
|
$2.70 M
|
$3.51 M
|
$2.62 M
|
$3.22 M
|
| Operating Expenses |
$24.68 M
|
$9.06 M
|
$13.17 M
|
$31.82 M
|
$36.63 M
|
$31.46 M
|
$27.12 M
|
$23.70 M
|
$21.07 M
|
$13.93 M
|
| Cost And Expenses |
$0.00
|
$8.93 M
|
$12.67 M
|
$33.98 M
|
$41.52 M
|
$36.57 M
|
$37.20 M
|
$29.00 M
|
$24.63 M
|
$19.56 M
|
| Interest Income |
$0.00
|
$12.00 K
|
$16.00 K
|
$362.00 K
|
$86.00 K
|
$93.00 K
|
$31.00 K
|
$2.00 K
|
$9.11 K
|
$7.45 K
|
| Interest Expense |
$0.00
|
$12.00 K
|
$16.00 K
|
$362.00 K
|
$86.00 K
|
$93.00 K
|
$31.00 K
|
$29.00 K
|
$7.03 M
|
$5.01 M
|
| Depreciation & Amortization |
$0.00
|
$70.00 K
|
$164.00 K
|
$397.00 K
|
$435.00 K
|
$457.00 K
|
$432.00 K
|
$335.00 K
|
$279.18 K
|
$315.77 K
|
| EBITDA |
-$24.68 M |
-$8.84 M |
-$14.70 M |
-$32.83 M |
-$34.57 M |
-$27.97 M |
-$32.72 M |
-$19.65 M |
-$27.89 M |
-$17.64 M |
| EBITDA Ratio |
0
|
67.99
|
29.4
|
-9.72
|
-5.01
|
-3.51
|
-8.21
|
-2.2
|
-8.21
|
-11.27
|
| Operating Income Ratio |
0
|
68.53
|
29.79
|
-10.05
|
-5.1
|
-3.59
|
-8.33
|
-2.24
|
-6.25
|
-11.5
|
| Total Other Income/Expenses Net |
$1.19 M
|
-$12.00 K
|
$16.00 K
|
$362.00 K
|
$586.00 K
|
$93.00 K
|
$31.00 K
|
$29.00 K
|
-$13.97 M
|
-$4.97 M
|
| Income Before Tax |
-$23.49 M
|
-$8.92 M
|
-$14.88 M
|
-$33.59 M
|
-$35.09 M
|
-$28.52 M
|
-$33.18 M
|
-$20.02 M
|
-$35.20 M
|
-$22.97 M
|
| Income Before Tax Ratio |
0
|
68.62
|
29.76
|
-9.94
|
-5.09
|
-3.58
|
-8.33
|
-2.24
|
-10.36
|
-14.68
|
| Income Tax Expense |
$0.00
|
$12.00 K
|
$0.00
|
$0.00
|
$172.00 K
|
$186.00 K
|
$62.00 K
|
$58.00 K
|
$0.00
|
$42.22 K
|
| Net Income |
-$23.49 M
|
-$8.93 M
|
-$14.88 M
|
-$33.59 M
|
-$35.09 M
|
-$28.52 M
|
-$33.18 M
|
-$20.02 M
|
-$35.20 M
|
-$22.97 M
|
| Net Income Ratio |
0
|
68.72
|
29.76
|
-9.94
|
-5.09
|
-3.58
|
-8.33
|
-2.24
|
-10.36
|
-14.68
|
| EPS |
-0.43 |
-0.82 |
-2.17 |
-54.81 |
-12.69 |
-12.64 |
-20.13 |
-12.37 |
-30.94 |
-14.61 |
| EPS Diluted |
-0.43 |
-0.82 |
-2.17 |
-54.81 |
-12.69 |
-12.64 |
-20.13 |
-12.37 |
-30.94 |
-14.61 |
| Weighted Average Shares Out |
$54.98 M
|
$10.94 M
|
$6.86 M
|
$612.83 K
|
$2.77 M
|
$2.26 M
|
$1.65 M
|
$1.62 M
|
$1.14 M
|
$1.57 M
|
| Weighted Average Shares Out Diluted |
$54.98 M
|
$10.94 M
|
$6.86 M
|
$612.83 K
|
$2.77 M
|
$2.26 M
|
$1.65 M
|
$1.62 M
|
$1.14 M
|
$1.57 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
